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TYPE 2 DIABETES MELLITUS INCREASES INFLAMMATION IN  
 
PERIODONTITIS THROUGH PROMOTING CD4+ T HELPER CELL  
 
CYTOKINE PRODUCTION 
 
SOPHIA HYUN KIM 
 
ABSTRACT 
 Periodontitis (PD) and type 2 diabetes mellitus (T2D) are chronic inflammatory 
diseases in which the host immune system encounters changes in its T and B cell 
distribution and function. Both disorders are increasingly prevalent in the U.S. and while 
T2D is a risk factor for periodontal disease, PD can exacerbate diabetes. Previous studies 
have unsuccessfully attempted to determine the underlying molecular mechanism for the 
relationships between T2D and periodontitis. To test directly the effect of T2D on 
periodontitis, I quantified cytokine production by gingival immune cells from three types 
of subjects: healthy, periodontal disease and T2D with periodontal disease, using single 
cells purified via flow cytometry and assessed for function with an enzyme-linked 
immunospot (ELISPOT) assay. The cells were sorted into subtypes according to CD45+, 
CD4+, CD8+, CD11b+, CD19+ and/or CD56+ expression, were stimulated by PMA, 
ionomycin or LPS, and were aliquoted into a well of a 96-well ELISPOT plate for 36 
hours. Outcomes showed that CD4+ is the predominant cell population in lymphocytes 
and that gingiva tissues from periodontitis/T2D group produced higher concentrations of 
cytokines characteristic of the Th1 T cell subset, namely IL-2, IL-10, TNF-α and IFN-γ 
(p<0.05, <0.001, <0.001, <0.01, respectively) compared to tissues from either healthy or 
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periodontitis group. This work illustrates that T2D increases inflammation in 
periodontitis through an increase in Th1 T helper cell function. 
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INTRODUCTION 
Periodontitis and type 2 diabetes mellitus: chronic inflammatory diseases 
 Chronic inflammatory diseases such as obesity, type 2 diabetes and 
periodontitis (PD) have high prevalence (CDC, 2014). In the United States, 47.2% of 
adults older than 30 years old have some type of clinically diagnosed periodontitis 
(Llambes et al, 2015) can exacerbate diabetes mellitus (Loe, 1993). On the other hand, 
diabetes is a risk factor for periodontal disease (Torrungruang et al, 2005; LONGO et al, 
2013). To understand the relationship between diabetes and perio diseases, multiple 
studies examined the influence of one state on the other. Compared to lean individuals, 
patients with diabetes had degeneration of the gingiva and calcification in and around the 
capillaries near gingiva tissues (Ray and Orban, 1950), which would prime the oral 
environment for gingival inflammation (Heiz et al, 2015). Also, retrospective analyses 
showed that severe periodontitis occurred two-fold more frequently in patients in diabetes 
than those without (Academy Reports, 1999; Genco et al, 2005).  
Diabetes mellitus is characterized by hyperglycemia, and the literature has largely 
focused on the effect of type 2 diabetes (T2D) on periodontal disease. The chronic high 
levels of blood sugar and insulin due to insulin resistance in T2D can increase 
proinflammatory metabolites such as free fatty acids, glucose and endotoxin, which can 
activate inflammatory signaling cascades through toll-like receptors (TLRs) and cytokine 
production. These signals prime the oral biome to hyper-react to oral pathogen (Zhu and 
Nikolajczyk, 2014). Obesity can exaggerate this immune perturbation even further. 
Previous studies extensively examined the relationship between obesity and 
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inflammation, and have proposed elevated concentrations of proinflammatory cytokines 
such as TNFα, leptin, IL-1β in obesity (Cottam et al, 2012; Nishimura et al, 2003). 
Because chronic inflammation and immune cells are key drivers of both diabetes and 
periodontitis, it is important to understand the biological connection between the 
developments of two diseases. However, a conclusive mechanism model is not yet 
established (Zhu and Nikolajczyk, 2014; Saito and Shimazaki, 2007; Genco et al, 2005). 
PD is defined as the alveolar bone loss due to chronic inflammation of the soft 
tissue and ligament around the infected tooth. Invasion by oral pathogen disturbs the host 
immune response toward chronic inflammatory state and the lipopolysaccharide (LPS) 
found in oral pathogen can further aid the bone resorption process by stimulating critical 
cytokines such as TNFα, IL-1 and PGE2 to promote osteoclast activity (Heiz et al, 2015). 
In addition to the bone destruction, the inflammatory response in PD initiates adaptive 
immune response by activating T and B lymphocytes. Activated T and B cells also 
perturb immune homeostasis by producing proinflammatory cytokines such as IL-1b, IL-
6, IL-8 and TNFα (Zhu and Nikolajczyk, 2014; Wilensky et al, 2014; Shaker and 
Hashem, 2012). The pattern of inflammatory cytokine production by T and B 
lymphocytes in PD significantly overlaps with that by adipose tissue in obesity and T2D 
and thus it is perhaps unsurprising that epidemiological studies have identified 
periodontitis as a risk factor for other inflammation-associated disorders such as obesity, 
arthritis and diabetes (Keller et al, 2015; Awad et al, 2015; Torrungruang et al, 2005). As 
mentioned earlier, hyperglycemia in T2D can lead to inappropriately strong activation of 
cells, which can prime the individual more susceptible to gingival infection and hyper-
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secretion of cytokines that can propagate inflammation (Zhu and Nikolajczyk, 2014). For 
example, cytokines such as IL-6, TNFα and lipid mediator lipopolysaccharide found in 
gram-negative bacteria can promote osteoclast differentiation and can therefore expedite 
PD progression (Heiz et al, 2015) The roles of other cytokines, including IL-2 and IL-4, 
are not yet clear. It is however generally agreed that both T and B lymphocytes are highly 
involved in the chronic stage of periodontitis (Zhu and Nikolajczyk, 2014; LONGO et al, 
2014).  
 
B lymphocytes in periodontitis and diabetes 
B cells play a critical role in both PD and T2D and potentially link the two 
clinical diseases. B cells serve as an antigen-presenting cell (APC) due to expression of 
major histocompatibility complex II (MHCII), and are well known to activate pro-
inflammatory T cells (Shin et al, 2008). B cells are also hypothesized to be a major 
source of cytokines in inflammatory state (Berglundh and Donati, 2007). In particular, B 
cells’ capacity to clear bacterial pathogen increases as the disease progresses (Wilton and 
Hurst, 1993). 
The cell distribution in periodontal lesions based on previous studies show that 
terminally differentiated B cells, i.e. plasma cells, are the predominant cell type (50%), 
followed by B cells (18%) and T helper cells (<5%) (Berglundh and Donati, 2005). In 
patients with PD, the gingival epithelial cells produce higher concentrations of IL-1b and 
TNFα that can prolong gingival inflammation (Miyauchi et al, 2001). Other studies also 
showed that B cells are the predominant population in periodontal lesion (Mackler et al, 
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1977; Lindhe et al, 1980; Seymour et al, 1988; and Renhardt et al, 1988). However, these 
studies utilized immunofluorescence and immunohistochemistry techniques, which are 
less than ideal because they cannot accurately quantify the antigen and can only estimate 
the immune reactivity (Luongo de Matos et al, 2010). 
Interestingly, B cells from T2D patients showed cytokine production patterns that 
were similar to those by B cells from lean PD patients (Nikolajczyk et al, 2012; DeFuria 
et al, 2013) and it is generally accepted that B cells from diabetes patients secrete higher 
levels of proinflammatory cytokines such as TNFα compared to non-diabetics 
(Jagannathan et al, 2010). Also, in vivo work using a well-controlled mice experiment 
showed that B cells promote both local and systemic inflammation in obesity-associated 
PD (Nikolajczyk et al, 2014). This justifies comprehensive examination of B cells as the 
potential immunological bridge between PD and T2D. 
T lymphocytes in periodontitis and diabetes 
T lymphocytes are also highly involved in inflammation-associated diseases such 
as PD and T2D. T cells are sub-categorized into CD4+ T helper cells and CD8+ T 
cytotoxic cells. T cells, especially CD4+ T helper cells, are regulated by innate immune 
cells such as neutrophils and dendritic cells (DCs) (Savill and Dransfield, 2002; O’Shea 
and Paul, 2010). CD4+ T cells use T cell receptors (TCRs) and associate with major 
histocompatibility complex II (MHCII) on the surface of their cells to recognize specific 
peptides required for activation while CD8+ T cells associate with MHCI present on their 
cell surface to recognize antigens, or “non-self” molecules or cells (O’Shea and Paul, 
2010). 
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CD4+ T cells also infiltrate and induce inflammation in expanding adipose tissue 
and can be sub-divided into population subsets. Th1 and Th17 cells are proinflammatory 
and Th2 and Tregulatory (Tregs) cells are anti-inflammatory (DeFuria et al, 2013; Denis 
et al, 2012; and Jagannathan-Bogdan et al, 2011) and specific ligands determine their 
differentiation (O’Shea and Paul, 2010). Previous studies showed that Th1 cells produce 
IL-2, IL-6, TNFα and IFN-γ, while Th2 cells produce IL-4, IL-5, IL-6, IL-10 and IL-13. 
There is a controversy over which T cell sub-population dominates in PD. Some literature 
demonstrates that Th1 predominates in a stable lesion while Th2 dominates a progressive 
lesion. For example, Fujihashi et al (1996) isolated gingival mononuclear cells (GMC) 
from inflamed gingival tissues and examined cell subpopulations via flow cytometry and 
concluded that about 20-30% were CD4+ T cells. Then they utilized reverse transcriptase 
polymerase chain reaction (RT-PCR) to determine the cytokine expression patterns. They 
detected two mRNA patterns, one that expressed IFN-γ, IL-6, IL-10 and IL-13 and 
another that showed IFN-γ, IL-6 and IL-13. Because both Th1 and Th2 cytokines were 
expressed in adult PD, the researchers concluded that both Th1 and Th2 environments co-
dominate in PD. Prabhu et al (1996) also utilized PCR amplification of gingiva using 
primers for IL-1α, IL-2, IL-4, IL-6, IL-8, IL-10, IFN- α, IFN-γ, TGF-β and IL-12 and 
ELISA to detect plasma cytokine levels. These data showed no significant difference 
between signals specific for Th1 and Th2 cells. Yamamoto et al (1997) sorted CD4+ 
subsets via flow cytometry and used RT-PCR to measure Th-1 cytokines (IL-2, IFN- γ) 
versus Th-2 cytokines (IL-4, IL-5, IL-6, IL-10 and IL-13) and observed no difference. 
However, other earlier studies showed that Th2 is the dominant T cell subset by using 
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FACS analysis and T cell monoclonal antibody for CD3, CD4 and CD8 and showed high 
concentrations of IL-4 (Wassenaar et al, 1995), RNA probing for IL-1α, IL-1β, IL-2, IL-
4, Il-5, Il-6 and TNFα for in situ analysis (Tokoro et al, 1997), and 
immunohistochemistry for IL-2, IL-4, Il-6, IL-10, IL-15, TNFα and IFN-γ and detected 
higher levels of IL-4, Il-6 than IL2 and IFN-γ (Lappin et al, 2001). Others used RT-PCR 
(Takeichi et al, 2000; Bickel et al, 2001) to show that Th1 is the dominant T cell subset. 
Although not based on experiments, a systematic review calculated cell distribution from 
34 PD lesion studies and determined that higher level of B cells are present in PD lesions 
than there are T cells and thus deduced that Th2-related cytokines dominate over Th1 in 
PD because Th2 cells are directly associated with B cells (Berglundh and Donati, 2008). 
It also has been proposed that non-progressive periodontal lesions are Th1 dominated 
(IFN-γ, IL-6) while progressive lesions are Th2-dominated (Berglundh and Donati, 
2005). 
While published studies emphasize the relationship between periodontitis and 
immune response, many of the previous studies relied on murine or rabbit models that 
cannot comprehensively reflect human immunity. Furthermore, the intravenous injection 
methods utilized in the animal models contrast from the actual mechanism of human 
periodontal disease onset (Zhu and Nikolajczyk, 2014; Lin et al, 2015).  
In obesity, the excess nutrient availability alters hormone and cytokine production 
and thus drives T cell differentiation toward classical proinflammatory subsets including 
Th1s and Th17s. However, the frequencies of these cells do not change in blood. Th1s 
are highly associated with inflammatory diseases such as arthritis and multiple sclerosis 
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and are a source of IFN-γ along with CD8+ cells (Jagannathan-Bogdan et al, 2011), which 
can stimulate macrophages to become activated and penetrate adipose tissue (Mosser and 
Edwards, 2008). Previous studies have also linked Th17 cells with inflammatory diseases 
(Pene et al, 2008; Jagannathan-Bogdan et al, 2011; Zuniga et al, 2010). Each T cell sub-
population produces specific cytokines. Th17 cells secret IL-17, IL-21, IL-22 and Mip-3 
that aggravate inflammation via NF-kB pathway (Onishi and Gaffen, 2010). Th17 also 
directly relate to glycosylated hemoglobin, (HbA1c) percentages, and are increased in 
obesity-associated T2D compared to metabolically healthy obese individuals (DeFuria et 
al, 2013; Zhao et al, 2014). Experiments with mice on high-fat diet also demonstrated 
that CD4+ and CD8+ cells are present in adipose tissues (Winer et al, 2009; Nishimura et 
al, 2009). 
The goals of this thesis are to identify immune cell functions in gingiva of people 
with periodontitis (PD) or periodontitis with type 2 diabetes (PD/T2D), and to precisely 
define the predominant cell type responsible for production of pathogenic cytokines. 
Understanding specific immunological responses will help to see which cells and 
cytokine are critical for chronic disease and provide validated targets for therapeutic 
intervention. Many studies relied on longitudinal data to summarize the risk factors 
(LONGO et al, 2013; Kiedrowicz et al, 2015; Liambes et al, 2015) and not specify the 
underlying molecular mechanism. Further, previous experimental designs relied on 
methods such as immunostaining, qPCR or microscopic observation, which could not 
accurately quantify the changes in cytokine production driven by the presence of oral 
pathogen or poor glycemic control. Another limitation is that many studies employed 
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murine or rabbit models that may not accurately represent human immunological 
mechanism. Furthermore, the artificial intravenous injection of oral pathogen in animal 
models cannot fully reflect the human PD that progress from natural infection routes and 
sustained inflammation of gingival tissue (Lin et al, 2015). Therefore, the goal of this 
project is to query the association between PD and T2D based on quantified cytokine 
production levels of IL-2, IL-4, IL-6, IL-8, IL-10, IL-13, IL-17, TNFα, IFN-γ, Granzyme 
B and Mip3 for the first time. 
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MATERIALS AND METHODS 
Subject Recruitment 
Gingiva tissues were resected from healthy subjects during standard crown 
lengthening procedures (n=4) or periodontal surgery (PD) (n=19), from or from subjects 
with chronic periodontitis and type 2 diabetes mellitus (PD/T2D) n=3. All tissues were 
obtained from the Boston University Henry M. Goldman School of Dental Medicine, 
Departments of Periodontics and general dentistry with informed consent and approval 
by the Boston University IRB. Exclusion criteria were those who had infections other 
than PD, alcohol or drug abuse, smoking, antibiotic or steroid use. The final subject 
population included males and females, ages from 19 to 69, and for the T2D group, 
subjects had HbA1c level of 6.5% or higher based on the previous patient records (Table 
3).  
 
Gingiva Sample Processing 
Each gingival tissue piece was placed in 15ml conical tube with RPMI Medium 
1640 (Gibco Life Technologies) supplemented with 10% Fetal Bovine Serum (Atlanta 
Biological, Norcross, GA) and 1% Penicillin-Streptomycin. The tube was placed on ice 
in a Styrofoam container and was transferred to the laboratory. The sample gingival 
tissue was thoroughly washed inside a 15 ml conical tube with Phosphate-Buffered Saline 
(PBS) (Corning Incorporated) under sterile conditions, using a 1000µl pipette to 
vigorously mix and rub away the blood clots. Blood clots were then aspirated using the 
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same pipette and the tissue was taken out of the medium with sterile tweezers and placed 
into a petri dish. The mass of the tissue sample was determined with an electronic scale. 
A pair of sterile razor blades was utilized to tear the gingiva sample into fine thin 
fragments on the petri dish. During the mechanical tissue disruption, 1 ml of collagenase 
was added to aid the tissue digestion and thus release the cells. A 2 ml pipette with the 
end snapped off was used transfer the tissue fragments into a new 15 ml conical tube and 
was filled with additional collagenase (10~12 ml) was added to completely fill the tube.  
The 15 ml conical tube containing the sample was then placed in a Bacterial 
shaker with Worthington Collagenase I (LS004196), 1 mg/ml, in Medium 199 (Gibco 
#11043-023) / BSA 1% at 200 rpm and 37°C and incubated for an hour. During that time 
a sample of previously frozen peripheral blood mononuclear cell (PBMC) was thawed in 
37°C water bath to be processed as control. The PBMC sample was allowed to sit in the 
water bath until a small piece of ice was remaining and during this time a 15ml tube of 
RPMI was placed on ice. The PBMC sample was then transferred to a 15 ml conical tube 
and was mixed with ice cold RPMI to minimize cell lysis. Diluted PBMCs were 
immediately spun down at 1200 rpm for 10 minutes. The sample was checked for pellet 
formation at the bottom of the tube and the supernatant was aspirated out of the tube for 
disposal. The remaining pellet was then resuspended with additional RPMI and kept on 
ice until the tissue cells were isolated. 
After an hour of tissue digestion in the bacterial shaker, the tissue sample was 
taken out of the shaker and poured on a 70 micron BD filter inside a clean petri dish. If 
the tissue fragments were stuck in the conical tube, 1 ml of RPMI was added to wash 
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them off and to make sure all cells were taken out into the filter. The remaining 
fragments were mashed against the filter mesh with the back of a 3 ml syringe to break 
down the tissue as much as possible. Additional RPMI was poured to wash the remaining 
particles. All wash-through liquid was collected with a 10 ml pipette and was placed into 
a new 15 ml conical tube. If there was a remaining space in the tube, RPMI was added to 
fill to the top. The tube containing the gingiva cells and the second tube with PBMC were 
placed in a centrifuge at 1200 rpm at room temperature for 10 minutes. After the spin, the 
tubes were taken out and were checked for presence of pellets at the bottom of the tubes. 
The supernatants were carefully aspirated out of the tubes. The cells were resuspended in 
1ml PBS and transferred to two new Eppendorf tubes. The two tubes were spun at 
2200rpm at room temperature for 6 minutes.  
During the 10 minutes spin the Zombie Aqua stain (Fixable Viability Kit, 
Biolegend) was prepared, then temporarily stored in the dark at 4 degrees Celsius. The 
Zombie Aqua stains for the dead cells in a sample and thus that will adsorb antibodies 
non-specifically during cell sorting with flow cytometry. The Zombie Aqua stain was 
taken out of the freezer and placed in a drawer for 10 minutes to thaw at room 
temperature. It was made sure that the stain was away from light and closed. The stain 
solution was 1:200 ratio, 1µl of Aqua mixed with 200µl of PBS. 
When cell were pelleted, the tubes were taken out of the centrifuge and 
supernatant was aspirated as completely as possible using the 1ml pipette. Fifty µl 
Zombie Aqua stain was added the remaining pellet and was resuspended to mix. The 
prepared tubes were placed in the dark on ice for 30 minutes. 
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Name of the staining 
solution Ratio Amount to be added (µl) 
Zombie Aqua 1:200 1 
CD4 APC 1:200 0.5 
CD8 Percp 5.5 1:400 0.5 
CD3 APC-Cy7 1:200 1 
CD11b PE-7 1:200 1 
CD45 PacB 1:200 1 
CD20 PITC 1:200 1 
CD19 BUV395 1:100 2 
CD56 Alexa700 1:100 2 
Table 1. Staining concentrations in 200µL for complete staining solution for flow cytometry 
 
Antibody Final concentration 
Primary 
Antibody in 
0.5ml PBS 
Final 
Concentration 
(µg/ml) 
Secondary 
Biotinylated 
Antibody in 
0.5ml PBSTB 
IL-2 1:60 8.5 1:60 8.5 
IL-4 15 µg/ml 7.5 1 µg/ml 0.5 
IL-6 15 µg/ml 7.5 1 µg/ml 0.5 
IL-8 1:60 8.5 1:60 8.5 
IL-10 1:60 8.5 1:60 8.5 
IL-13 1:60 8.5 1:60 8.5 
IL-17 5 µg/ml 10 4 µg/ml 2 
TNFα 1:60 8.5 1:60 8.5 
IFNγ 15 µg/ml 7.5 1 µg/ml 0.5 
Granzyme B 1:60 8.5 1:60 8.5 
MIP 3α 5 µg/ml 10 2 µg/ml 1 
Table 2. Antibody titration concentrations for ELISPOT preparation. 
A 10-color flow cytometry solution formulated by Boston University Flow Core 
Facility was prepared (Table 1) for flow cytometry and was kept in the dark at 4 degrees 
Celsius. Also during this time, a 96 well plate for enzyme-linked immunospot assay 
(ELISPOT) (Milipore, #MAHA or MAIP) was coated with primary antibody specific for 
IL-2, IL-4, IL-6, IL-8, IL-10, IL-13, IL-17a, TNFa, IFN-γ, mip3 and Granzyme to make 
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sure the plate was incubated for 5-6 hours at room temperature to receive sorted cells. 
The antibody solution was prepared based on the concentration determined by the 
manufacturer (Table 2). After 30 minutes, 1.2 ml of PBS was added to both the gingival 
cells and PBMC. The tubes were centrifuged at 2200) rpm for 6 minutes. The supernatant 
was taken out slowly with a 1ml pipette and discarded. Fifty µl of flow cytometry stain 
solution was added to the tubes and left in dark on ice for additional 30 minutes. Finally, 
the samples were washed with 1ml FACS buffer and centrifuged at 2.2(x100)rmp for 6 
minutes. The supernatant were aspirated carefully and discarded. The pellets were mixed 
with 200µL of FACS buffer (Aria) and were transferred to FACS tubes. 
Five Eppendorf tubes with 150µL RPMI were prepared to catch the sorted cell 
populations from the FACS (Aria). The cells were isolated according to surface 
expression of CD45+, with subpopulations defined by CD4+ (T helper cells), CD8+ 
(cytotoxic T cells), CD11b+ myeloid cells and CD19+ B cells. The cell count was 
recorded on the tubes with a permanent marker. 
FloJo software was utilized to calculate the frequencies of cell types in the 
samples via gating strategy, in which cells were quantified and sorted for T helper cells 
CD4+, cytotoxic T cells CD8+, B cells CD20+, myeloid cells CD11b+ and natural killer 
cells CD56+ (Figure 1). 
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Figure 1. Gating strategy to quantify and sort T helper cells CD4+, cytotoxic T cells CD8+, B 
cells CD20+, myeloid cells CD11b+ and natural killer cells CD56+ 
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Cytokine Production 
Enzyme-linked Immunospot (ELISPOT) assay 
The sorted cells were taken back to the laboratory to be aliquoted onto the 
previously prepared ELISPOT plate. The plate was washed twice with 200µl PBS and 
twice with 200µl RPMI, then left for 15 minutes in the incubator with 50µl RPMI per 
well. For each washing step, the plate was manually tapped upside down on paper towels 
to remove liquid from the wells as much as possible. The cells were divided by subtype 
to have at least 250 cells from an individual subset per well. After adding the cells, 
CD45+, CD4+, CD8+ and B cells were stimulated with 100µl PMA and ionomycin and 
CD11b+ were stimulated with LPS. PMA, ionomycin and LPS are activators and that 
stimulate the cells to produce cytokines. 
 
Secondary Antibody Capture 
After 36-40 hours incubation at 37°C, the plate was washed twice with 200µl PBS 
and twice with PBST (prepared with PBS+0.1% Tween; 1:1000). Tween is a detergent 
that decreases non-specific adherence and PBST washes the cells labeled with primary 
antibodies. A solution for biotinylated (secondary) antibody capture was prepared in 
0.5ml PBSTB (PBS+0.1% Tween +2% BSA) according to the titration determined by the 
Flow Core (Table 2). Fifty µl of the biotinylated antibody was added to each well and the 
plate was incubated for at least 24 hours at 4°C. The plate was wrapped in moist paper 
towels to ensure moist environment for the antibodies.  
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Final Stain 
On the third day of the experiment the plated cells were washed twice with 200µl 
PBST per well. A solution of 5µl streptavidin (AP-Conjuated Streptavidin, Jackson 
Immunoresearch, 016-050-084) in 5ml PBSTB (1:1000) was added at 50µl per well. 
Steptavidin is a protein isolated from the bacterium Streptomyces avidinii, and allows for 
strong non-covalent bond with the biotin that is resistant to detergents, enzymes or 
organic molecules. After an hour, the plate was washed twice with 200µl PBST. The 
rubber backing of the ELISPOT plate was removed, and the main plate was soaked in 
PBS for an hour under non-sterile conditions. During this time, the final staining solution 
was prepared with 1ml Tris buffer (100mM Tris HCL, pH 8.2), 9ml of PBS (1:10). 
Vector blue substrate mix (AP Substrate Kit III, Vector Labs, #SK-5300) was prepared 
and stored in a dark place at room temperature. The plate was washed again with PBS by 
directly pouring PBS on the plate. The plate was tapped well upside down on dry paper 
towels to dry the wells as much as possible and 90µl of final stain solution was added per 
well in a darkened room. During this step, it was made sure that the bottoms of the wells 
do not touch any surface to prevent any perturbation of the captured antibodies on the 
bottom of the wells. The plate was left in dark and was checked every 25-30 minutes for 
2.5-3 hours until spots were visible (Figure 2). Finally, the plate was tapped to remove 
any liquid from the wells and left to dry.  
After the plate had dried, the spots in each well were counted under a microscope 
to calculate percentage of cytokine-producing cells as # spots/total number of cells 
plated. 
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Figure 2. An example of a row of ELISPOT plate after the final stain. 	    
	  18	  
RESULTS 
Patient Demographics 
 Total CLP Periodontitis Periodontitis and type 2 diabetes 
n 26 4 19 3 
Mean probing 
depth of the site of 
tissue excision 
(mean ± SD) 
 2.75 (± 0.5) 6.6 (± 2.6) 8.6 (±3.2) 
Males  1 5 2 
Females  3 14 1 
BMI (mean ± SD)  24.48 ± 3.87 27.63 ± 4.66 25.4 ± 0.35 
Table 3. Patient demographic results of healthy, PD and PD/T2D  
 
For this project, three types of patients, healthy (CLP), periodontitis (PD) and 
periodontitis with type 2 diabetes mellitus (PD/T2D) were recruited to assess the effect of 
T2D on specific cytokine productions in periodontitis (Table 3). CLP is the control for 
the non-periodontal disease state and PD served as the control for non-diabetic 
periodontal disease state and PD/T2D was compared to the two groups. One-way 
ANOVA was utilized to calculate the statistical significance in percentage of cells 
producing cytokines among these groups. 
Statistical Analysis 
One-way ANOVA was also utilized to determine the statistical significance of 
BMI on the cytokine producing cells among the three groups. P value of  <0.05 
established statistical significance. 
An overall F Test for one-way ANOVA was performed via the POWER 
procedure to determine the significance of each cytokine production level. Computed 
power value of 0.8 or greater is identified as critical by standard.   
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First, the frequency of cell types per each subpopulation were calculated as 
percent of total CD45+ cells in gingival tissues to determine which cell subgroup was 
predominant among the three types of gingival tissues (Figure 3). The cell frequencies 
were obtained from the gating strategy (Figure 2). There was no significant difference in 
gingival immune cell distribution among healthy, periodontitis (PD) and periodontitis 
with type 2 diabetes (PD/T2D). Analysis of the cell distribution showed that CD4+ cells 
are the predominant cell type among the three clinical groups (26-31%, SE±1.81-4.21), 
followed by CD8+ cells (18.5-22.5%, SE±1.28-5.82), CD11b+ (12%, SE±1.47-4.59), 
CD19+ (5-7.5%, SE±0.69-1.19) and finally CD56+ (2-3%, SE±0.11-0.66) (Figure 3). 
      
Figure 3. CD45+ cell sorted and frequencies expressed as percent total in healthy vs. PD vs. 
PD/T2D 
 
CD4+ T helper cells 
T lymphocytes play a critical role in PD as part of the host adaptive immune 
response by activating macrophages and producing inflammatory cytokines. T cells can 
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be subdivided into CD4+ T helper cells and CD8+ T cytotoxic cells and have different 
functions and requirements for their activation such as MHCII for CD4+ and MHCI for 
CD8+ (O’Shea and Paul, 2010). Therefore, CD4+ and CD8+ T cells were sorted and 
analyzed separately. Table 4a show the mean values of CD4+ T helper cell cytokines and 
the overall cytokine profiles from the three groups. PD/T2D CD4+ T helper cells secreted 
significantly higher levels of IL-2, IL-10, TNFα and IFN-γ after 36-hr stimulation (IL-2: 
p<0.05, IL-10 and TNFα <0.01 and IFN-γ p<0.001) (Table 4a, Figures 4a, 4b). Further, 
healthy group CD4+ cells generally showed the lowest concentrations of cytokine 
secretion compared to PD and PD/T2D cells. The mean IL-2 secretion in healthy was 
1.3% (SE±0.98), in PD 3.66% (SE±0.93), and in PD/T2D 8.63% (SE±3.05), (p=0.05). 
The mean TNFα production in healthy was 2.33%, in PD 2.6% and PD/T2D (7%) 
(p<0.001). The mean IFN-γ secretion in healthy was 3.9%, in PD 4.2% and PD/T2D 
(10%) (p<0.01). The mean IL-10 production the lowest in PD with 0.15%, followed by 
healthy 0.3% and PD/T2D 1.2% (p<0.001). The ELISPOT wells for CD4+ IL-4, IL-6, 
IL-8, IL-13, IL-17, Granzyme B and Mip3 showed minimal spots and did not reach 
statistical significance. However, cytokine production in IL-17 and Mip3 trended toward 
lower in the healthy group and highest in the PD/T2D (Figure 4c). Also, posthoc test of 
overall F test of one-way ANOVA revealed that Mip3 secretion had power of 0.971 
(Table 4b).  
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Figure 4a. Overall CD4+ cytokine production by percent total in healthy vs. PD vs. PD/T2D 
 
 
CD4+ Healthy Periodontitis Perio/T2D P value by one way ANOVA 
IL-2 1.33 3.59 8.64 <0.05 
IL-4 0.32 0.22 0.13 - 
IL-6 0.12 0.01 0.04 - 
IL-8 0 0.25 0.42 - 
IL-10 0.37 0.17 1.26 0.0001 
IL-13 0 0.11 0.05 - 
IL-17 1.01 1.26 1.28 - 
TNF-α 1.89 2.75 7.04 0.00012 
IFN-γ 4.46 4.15 10.16 <0.01 
Granzyme B 0.08 0.31 0.43 - 
Mip 3 1.41 1.85 3.67 0.314 
Table 4a. Mean values of cytokine secretion by percent of total cells for CD4+ cells for 
healthy vs. PD vs. PD/T2D 
 
 
CD4-Mip3 
Computed power 0.971 
Method Exact 
Alpha 0.05 
Group means 1.56  1.31  3.67 
Standard deviation 0.855 
Group sample sizes 4  20  3 
Table 4b. Posthoc test values of CD4-Mip3 via overall F test for one-way ANOVA 
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Figure 4b. CD4+ IL-2, IL-10, TNFα and IFN-γ productions by percent total in healthy vs. 
PD vs. PD/T2D after 36-hr stimulation. *P<0.05, **P<0.01, ***P<0.001 
 
 
 
                                
Figure 4c. CD4+ IL-17 and Mip3 cytokines production in healthy vs. PD vs. PD/T2D  
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CD8+ T cytotoxic Cells 
As another subset of T cells, CD8+ T cytotoxic cells also play a critical role in 
inflammatory diseases such as PD and T2D by traveling to infected tissue where the 
pathogen-infected cells present specific antigen, which they can recognize with MHCI 
present on their cell surfaces (O’Shea and Paul, 2010). Therefore, CD8+ cytokine 
secretion was measured in the three groups. As figure 5 demonstrates, the assay for 
overall CD8+ cytokine secretion by percent total showed production of IL-2, TNFα, IFN-
γ and Granzyme B without statistical significance among the three groups (Figure 6). 
Table 5a shows the mean values of each CD8+ cytokine production for healthy, PD and 
PD/T2D. However, the posthoc test analysis showed that the computed power for CD8-
IL2 is 0.774 and CD8-IFN-γ is 0.699, which fail to achieve the statistically critical value 
of 0.8 (Tables 5b and 5c). 
 
 
Figure 5. Overall CD8+ T cytotoxic cells cytokine production by percent total in healthy vs. 
PD vs. PD/T2D 
0	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10	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Figure 6. CD8+ IL-6, IL-8, TNFα (top) and CD11b+ IL-2, TNFα, IFN-γ and Granzyme B (bottom) 
productions by percent total in healthy vs. PD vs. PD/T2D 
 
CD8+ Healthy Periodontitis Perio/T2D P value by one way ANOVA 
IL-2 5.80 4.69 7.77 - 
IL-4 0 0.34 0.26 - 
IL-6 0.18 0.04 0 - 
IL-8 0.18 0.02 0.16 - 
IL-10 0 0.04 0.12 - 
IL-13 0 0.02 0.15 - 
IL-17 0.56 0.02 0.04 - 
TNFα 5.33 6.55 9.51 - 
IFN-γ 17.06 13.06 12.38 0.307 
Granzyme B 3.27 2.52 5.96 1 
Mip 3 0.54 0.10 0.15 0.0058 
Table 5a. Mean values of CD8+ T cytotoxic cell cytokine production for healthy vs. PD vs. 
PD/T2D 
 
CD8-IL-2 
Computed power 0.774 
Method Exact 
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Alpha 0.05 
Group means 7.44  4.91  7.77 
Standard deviation 1.9 
Group sample sizes 4  20  3 
Table 5b. Posthoc test result for CD8-IL2  
CD8- IFN-γ 
Computed power 0.699 
Method Exact 
Alpha 0.05 
Group means 20.49  12.7  12.38 
Standard deviation 4.9 
Group sample sizes 4   20  3 
Table 5c. Posthoc test result for CD8- IFN-γ 
 
CD11b+ Myeloid Cells 
Myeloid cells are also APCs and present antigens to T lymphocytes. They serve 
as the bridge between innate and adaptive immune system in PD, especially by helping 
CD4+ T helper cell differentiation (Wilensky et al, 2014). Therefore, CD11b+ myeloid 
cell cytokine secretion was measured. As figure 7 demonstrates, the assay for overall 
CD11b+ myeloid cell showed cytokine production for IL-6, IL-8, TNF-α and Granzyme 
B without statistical significance in healthy vs. PD vs. PD/T2D. Also, as table 6 shows, 
the cytokine productions in CD11b+ cells were low. Posthoc F test analyses showed 
computed power values of 0.552, 0.587 and 0.581 for IL-6, IL-8 and TNFα, respectively 
(Table 7).  
	  26	  
Figure 7. Overall CD11b+ myeloid cell cytokine production by percent total in healthy vs. PD. vs. 
PD/T2D 
CD11b+ Healthy Periodontitis Perio/T2D P value by one way ANOVA 
IL-2 - 0 0 - 
IL-4 1.67 0 0 - 
IL-6 4.23 1.45 2.17 - 
IL-8 12.60 6.69 4.25 - 
IL-10 - 0.08 0.61 - 
IL-13 - 0 0 - 
IL-17 - 0 0.16 - 
TNFα 12.78 2.08 0.86 - 
IFN-γ 0 0.57 0 - 
Granzyme B - 0.62 1.33 - 
Mip 3 - 0.54 0.82 - 
Table 6. Mean values of CD11b+ myeloid cell cytokine production for healthy vs. PD vs. 
PD/T2D 
 CD11b-IL-6 CD11b-IL8 CD11b-TNFα 
Computed Power 0.552 0.587 0.581 
Method Exact Exact Exact 
Alpha 0.05 0.05 0.05 
Group Means 5.47  2.03  2.17 18.16  8.17  4.25 7.34  2.43  0.861 
Standard Deviation 2.51 7.79 3.76 
Group Sample 
Sizes 4  20  3 4  20  3 4  20  3 
Table 7. Posthoc analysis results for CD11b-IL-6, CD11b-IL8, CD11b-TNFα 
-­‐5	  0	  
5	  10	  
15	  20	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CD19+ B cells and CD56+ Natural Killer cells 
 
The importance of B lymphocytes in inflammatory diseases such as PD and T2D 
is critical, especially because they may promote obesity-associated PD and inflammation 
(Zhu and Nikolajczyk, 2014) and also may be the link between obesity-associated T2D 
and PD (Zhu and Nikolajczyk, 2014). However, in this study, the number of B cells 
collected from flow cytometry were too low to be statistically significant (Table 8). Also, 
CD56+ natural killer cell frequencies were too low or absent so the data for NK cell 
frequencies is not available.  
 
CD19+ Healthy Periodontitis Perio/T2D P value by one way ANOVA 
IL-2 - 0 0.18 - 
IL-4 0.36 0.21 0 - 
IL-6 0.46 1.65 2.50 - 
IL-8 1.41 0.88 4.00 - 
IL-10 - 0.22 0.18 - 
IL-13 - 0.05 0.18 - 
IL-17 - 0.30 0.18 - 
TNFα - 0.75 1.11 - 
IFN-γ - 0.09 0 - 
Granzyme B - 0 0.18 - 
Mip 3 - 0 0 - 
Table 8. Mean values of CD19+ B cells cytokine production for healthy vs. PD vs. PD/T2D 
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DISCUSSION 
The increasing prevalence of periodontal diseases and diabetes in the United 
States and the clinical link between the two diseases justify a thorough investigation of 
the pathogenesis of these diseases. In doing so, researchers are likely to identify potential 
therapeutic targets that reduce inflammation or prevent progression of these diseases. 
Epidemiological and experimental studies have previously associated periodontitis with 
diabetes or vice versa but could not determine clear immunological link between them 
due to study design limitations. Herein my data show that CD4+ T helper cells are the 
predominant immune cell subpopulation in gingiva samples from healthy (n=4), PD 
(n=19) and periodontitis (PD/T2D, n=3) and CD4+ T cells from PD/T2D produced the 
highest concentrations of IL-2, IL-10, TNFα and IFN-γ with statistical significance, 
followed by PD and healthy groups (p<0.05, <0.001, <0.001, <0.01, respectively). IL-17 
and Mip3 production levels showed a similar trend with no statistical significance. 
However, PD/T2D cells trended toward highest production while healthy cells trended 
toward the opposite.  
  Furthermore, significantly increased production of IL-2, IL-10, TNFα and IFN-γ 
by the CD4+ subset indicates that Th1 subset is the predominant population. Our finding 
contrasts to some of the previous findings (Wassenaar et al, 1995; Tokoro et al, 1997; 
Lappin et al, 2001) that relied on relatively imprecise quantitative techniques such as 
immunofluorescence or immunohistochemistry (IHC). For example, IHC measures the 
concentration of immunoglobulin, which can bind to a myriad of substrates. Also, RT-
PCR or qPCR are also less than ideal techniques because to quantify cytokine production 
	  29	  
because these methods examine DNA or mRNA concentrations and not protein. Our 
approach demonstrates for the first time a functional analysis of gingival immune cells 
from healthy, periodontitis and periodontitis with type 2 diabetes at a single cell level for 
cytokine production by combining flow cytometry and ELISPOT.  
 BMI analysis of the three groups via one-way ANOVA showed no statistical 
difference. However, for future studies it would be interesting to analyze the association 
of plasma leptin levels and cytokine production. Leptin is a hormone secreted by white 
adipocytes. In obesity, excess amount of fat and subsequent elevation in leptin 
concentration contribute to inflammation because leptin is important in pro-inflammatory 
T cell differentiation. For example, Reis et al (2015) showed that leptin receptor signaling 
is required for Th17 differentiation in mice. Others also showed that leptin fuels energy-
costly T cell activation by up-regulating glucose uptake and maximizing lactate 
production (Saucillo et al, 2013; Yu et al, 2013). Interestingly, studies observed higher 
serum leptin levels in chronic periodontitis (Gundala et al, 2014; Reis et al, 2015). 
Therefore, it would be important to expand patient demographics to include serum leptin 
levels to analyze its influence on PD/T2D patients for future studies. 
 One limitation of this study may be the absence of % HbA1c data for each 
subject, because dental school records do not record this parameter. However, only the 
patients with official medical record of T2D, albeit lack of specific parameter, were 
recruited for the PD/T2D group. For future studies, HbA1c levels may be useful to recruit 
patients with pre-diabetes to expand subject pool.  
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IL-2 was detected in both CD4+ T helper cells and CD8+ T cytotoxic cells, which 
raises the possibility that IL-2 may be useful as a predictor of PD onset or pathogenesis 
and may be chosen as a potential therapeutic target for local immunotherapies. Many 
studies showed that IL-2 is critical in cell differentiation and function. IL-2 combined 
with IFN-γ promotes CD8+ T cytotoxic cell maturation into memory and effector cells in 
the presence of an antigen (Romagnani S, 1994). IL-2 can also direct naïve T cell to 
differentiate into either Th1 or Th2 while preventing Th17 cell differentiation. 
Interestingly, IL-2 facilitates Th17 function if the cell had already differentiated into 
Th17 (Liao et al, 2013). In addition, IL-2 promotes Treg cell differentiation at low levels. 
The role of B cells and T cells in PD and T2D is complicated and recent studies 
have begun to dissect the pathogenic roles of these lymphocytes. Studies have shown that 
B cell depletion therapy (BCDT) can impede the development of experimental 
encephalomyelitis (Hauser et al, 2008, Matshushita et al, 2008) and have shown B cell 
dominance in periodontal lesions. However, the number of B cells and monocytes sorted 
throughout this project were limited and may explain why analysis of B cell cytokine 
production did not reach statistical significance. Possible explanations for the discrepancy 
could be are not fully extracted with collagenase or that the cells die before getting 
aliquoted on the ELISPOT plate. For future studies, careful attention to B cell culture 
may be necessary. Plasma cells are the result of mature B cells and so it is possible that 
CD19+ B cells were disregarded along with plasma cells because they were differentiated 
into plasma cells. 
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This project showed that type 2 diabetes elevates inflammation in periodontal 
disease by promoting Th1 cell cytokines, IL-2, IL-10, TNF-α and IFN-γ with statistical 
significance. Considering that the gingival tissues were from progressive lesions, the data 
contrast to some of previous literature that Th2 dominates in progressive lesions 
(Wassenaar et al, 1995; Tokoro et al, 1997; Berglundh and Donati, 2005) and that Th1 is 
predominant in stable lesions (Bickel et al, 2001). However, the methods utilized in these 
studies were less than ideal. Tokoro et al (1997) utilized in situ hybridization-based 
techniques on gingival samples and measured the cell density that was  positive for 
specific cytokines. They found that Th2 cytokines, IL-4, IL-5, and Il-6 were significantly 
higher and Th1 cytokine, IL-2 was absent from both PD and healthy controls and 
concluded that Th2 is the predominant environment. However, they did not use any Th 
cell marker (CD4+). In another study by Yamamoto et al (1997) did utilize a cell marker 
for CD4+, and showed that IL-2, IL-4 and IL-5 were absent while IFN-γ, IL-6, IL-10 and 
IL-13 were detected. Because only one Th1 cell cytokine was produced and three Th2 
cell cytokines were detected, they concluded that Th2 is the predominant environment for 
progressive lesions.  
In addition to these studies that attempted to distinguish between Th1 and Th2 in 
progressive PD, other studies using methods comparable to this study also assessed the 
Th1 vs. Th2 difference but could not find any difference. Fujihashi et al (1996) collected 
gingival mononuclear cells (GMC) from gingiva tissues and sorted cells via flow 
cytometry and utilized RT-PCR to detect cytokines. They found that mRNA for IL-6, IL-
10, IL-13 and IFN-γ were expressed while mRNA for IL-2, IL-4 and IL-5 were not. In 
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another study using PCR and ELISPOT, significantly higher levels of IL-6 and IFN-γ 
were expressed in the PD samples (Prabhu et al, 1996). However, in this study, the 
systemic mRNA levels for other cytokines in PD and healthy control showed no 
difference. Another study also combined flow cytometry and RT-PCR and to isolate and 
characterize CD4+ T cell subsets. The results showed that either the expression of mRNA 
for IFN-γ, IL-6, IL-10 and IL-13 or mRNA for IFN-γ, IL-6 and IL-13 were detected. 
However, in this study the total sample number (n), the clinical characteristics of lesion 
site were not specified (Yamamoto et al, 1997). 
By employing flow cytometry and ELISPOT to sort for specific cell 
subpopulations and to directly quantify cytokine production, this project provides more 
accurate evidence to which Th environment dominates in progressive PD lesions. And as 
the data shows, there were increased concentrations of CD4+ T helper cell cytokines IL-2, 
IL-10, TNFα, IFN-γ, demonstrating that Th1 predominates in PD and PD/T2D. 
Moreover, the elevated concentration of IL-2 in both PD and PD/T2D suggests that IL-2 
may an effective therapeutic target for periodontitis and type 2 diabetes. 
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